President and CEO
President & Chief Executive Officer
For over three decades I treated families with bleeding disorders, working towards finding better treatments for patients and preventing complications of their disorders through education, advocacy, and research. My work was most gratifying when I could help someone realize his or her full potential, living a life not limited by a diagnosis or its complications. Diagnosing and treating boys and girls, men and women, parents, grandparents and family members was fulfilling personally and professionally. Conducting clinical and laboratory research helped me to understand how to develop and elevate treatments to new levels, seeking cures and improving the quality of life for everyone in the bleeding disorders community. I have spent time in the biopharmaceutical industry trying to understand how to bring new therapies to patients globally. My past experiences as a physician, educator, researcher, and an industry partner have all focused on treating patients and their families and have provided me with the experiences and knowledge to take on this challenging role as the President and CEO for the National Hemophilia Foundation, a role I take on behalf of the entire bleeding disorders community and one that I see as the pinnacle of my career – serving you.
The landscape of the bleeding disorders community is changing and there are challenges ahead. Gene therapy and novel technologies and treatments bring new opportunities, and many questions as well. We will face these challenges together, working jointly to find solutions. Through collaboration with patients, families, chapters, partners, supporters, medical professionals, patient organizations, government agencies, and all stakeholders in the bleeding disorders community, everything is possible. I believe in unity, and my past leadership roles in these areas put us in a unique position to move forward in ways we haven’t had the opportunity to do so ever before. To unlock our greatest potential in such an exciting time we must all support each other – this is what will define our success.
This is an exciting time for the bleeding disorders community as research is progressing forward in unimaginable ways, but there is still more to be done. This is why one of my primary objectives will be to increase our funding to support innovative research on new therapies, and then educating stakeholders on these advancements. Advocating on behalf of those impacted by bleeding disorders with our legislators locally and in Washington D.C. for better access, including access to care, to treatment centers, to physicians, and to new treatments will be ever more important.
I look forward to working with you in our joint pursuit to improve the outcomes for our community.
She, Her, Hers
Chief Operating Officer
Dawn has been a leader in the bleeding disorders community for many years. As a parent of a son with hemophilia, she founded the Rocky Mountain Hemophilia & Bleeding Disorders Association in Bozeman, Montana, served as its Executive Director, and began their Family Camp. After moving to Pittsburgh, Pennsylvania, Dawn worked for the American Diabetes Association (ADA) as an Area Manager. Concurrently, she served as a board member for the Hemophilia Center of Western Pennsylvania for six years. Dawn left the ADA for a position as the Executive Director of the Western Pennsylvania Chapter of the NHF in Pittsburgh, where she became actively involved with Camp Hot to Clot and eventually became the Director. She holds a Bachelor of Science from Montana State University in Bozeman.
Michael Recht, MD, PhD, MBA
He, Him, His
Chief Medical and Scientific Officer
Dr. Michael Recht entered the role of Chief Medical and Scientific Officer at the foundation in early 2023.
Prior to this role, he served as the Chief Science Officer (CSO) of the American Thrombosis and Hemostasis Network (ATHN). As ATHN's CSO, Dr. Recht worked at the strategic and policy level to inform the scientific direction of the organization.
In addition to his role as ATHN's CSO, Dr. Recht, a pediatric hematologist and Professor of Clinical Pediatrics at Yale University School of Medicine, sees children and young adults affected by non-malignant blood conditions, particularly bleeding and clotting disorders. As a member of the Division of Pediatric Hematology/Oncology, he contributes to the care of children with blood disorders at Yale New Haven Children's Hospital.
Before assuming his role as ATHN's CSO, Dr. Recht was previously the director of the Hemophilia Center at Oregon Health & Science University in Portland, OR as well as the director of the Mountain States Hemophilia Network, the federally-supported collaboration of Hemophilia Treatment Centers in the states of Alaska, Arizona, Colorado, Idaho, Montana, New Mexico, Oregon, Utah, Washington and Wyoming.
Dr. Recht has actively participated in over 110 clinical research trials testing new treatments for children with bleeding and clotting disorders, including being a leader in research involving gene therapy for hemophilia.
Peter Harvey, MBA
He, Him, His
Chief Business Officer
Peter Harvey serves as the Chief Business Officer for NHF including oversight for finance & accounting, business development, conference & travel services, payer relations, and IT. Peter is a senior healthcare finance and operations executive with diverse experience in healthcare nonprofit finance & accounting, pharma/biotech HEOR and medical affairs business operations, academic medical/pediatric department and Hemophilia Treatment Center administration, plus PM&R medical practice and research foundation executive leadership. Peter has volunteered at a number of non-profits and is a founding volunteer board member of a nonprofit providing education and humanitarian support to children and families in Mariani, Haiti. He has a B.A. in Biology from Augustana College and a M.B.A. from the University of Chicago, Booth School of Business in Finance and Healthcare.
He, Him, His
Vice President of Advancement
Brett is an innovative nonprofit executive with more than 20 years of experience in the healthcare nonprofit field. As the Vice President of Advancement, Brett leads theNHF's development, communications, marketing, and walk programs. Brett possesses significant experience in fundraising, including annual fund programs, major gifts, corporate and foundation development, special event fundraising, capital campaigns, and planned giving efforts. He has created and managed successful communications initiatives, including marketing, media relations and social media development, along with board governance and structure. Brett previously held leadership positions at Autism Speaks, The Alzheimer's Association, The ARC, The American Society for Parenteral and Enteral Nutrition, and the American College of Cardiology. He is also actively involved with the American Society of Association Executives, the Association of Fundraising Professionals, The Center for Nonprofit Excellence, and Board Source. Brett attended George Mason University, where he completed his undergraduate and graduate work in communications and public administration.
Conference & Travel Services
Finance and Administration
Health Equity, Diversity, and Inclusion
Medical Programs and Information
Neil Frick, MS
He, Him, His
Senior Vice President for Medical Programs and Information
New York, NY
Responsible for the overall strategic and operational leadership of the National Hemophilia Foundation's (NHF) medical programs and HANDI Information Resource Center including oversight of the processes of material development, update and distribution channels. Supervise the awarding of clinical fellowships and other health care provider awards. Support the work of NHF's Medical and Scientific Advisory Council and supervise NHF's continuing education program serving bleeding disorders treatment professionals. This includes the development of healthcare provider publications, pre-conference symposium and medical program tracks at NHF's Bleeding Disorders Conference and webinars.